Juvic

Juvic is a South Korean biotechnology company specializing in the development of dissolving microneedle (DMN) technology for effective drug delivery. Spun off from Yonsei University, the company focuses on overcoming the limitations of traditional injections by providing a painless, stable, and efficient method for administering biologics, vaccines, and cosmetic ingredients. Juvic's platform ensures the stability of heat-sensitive drugs and enables precise dosage control through its proprietary Centrifugal Lithography (CLL) fabrication process. The company collaborates with major pharmaceutical firms like Dong-A ST to develop microneedle-based treatments for chronic conditions such as growth hormone deficiency and diabetes.